Understanding the differences among inotropes. (Q53719697)

18 May 2018

title

Understanding the differences among inotropes. (English)

1 reference

18 May 2018

author

Mattia Arrigo

series ordinal

1

1 reference

18 May 2018

Alexandre Mebazaa

series ordinal

2

object named as

Alexandre Mebazaa

1 reference

18 May 2018

publication date

21 January 2015

1 reference

18 May 2018

published in

Intensive Care Medicine

1 reference

18 May 2018

volume

41

1 reference

18 May 2018

issue

5

1 reference

18 May 2018

page(s)

912-915

1 reference

18 May 2018

Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine.

cites work

1 reference

https://api.crossref.org/works/10.1007/S00134-015-3659-7

Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00134-015-3659-7

Levosimendan: molecular mechanisms and clinical implications: consensus of experts on the mechanisms of action of levosimendan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00134-015-3659-7

Cardiac inotropes: current agents and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00134-015-3659-7

The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00134-015-3659-7

Levosimendan vs. dobutamine: outcomes for acute heart failure patients on beta-blockers in SURVIVE

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00134-015-3659-7

Clinical review: practical recommendations on the management of perioperative heart failure in cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00134-015-3659-7

The effectiveness of inodilators in reducing short term mortality among patient with severe cardiogenic shock: a propensity-based analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00134-015-3659-7

Effects of dobutamine on systemic, regional and microcirculatory perfusion parameters in septic shock: a randomized, placebo-controlled, double-blind, crossover study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00134-015-3659-7

Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00134-015-3659-7

Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00134-015-3659-7

Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00134-015-3659-7

Short-term survival by treatment among patients hospitalized with acute heart failure: the global ALARM-HF registry using propensity scoring methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00134-015-3659-7

The Heart in Sepsis: From Basic Mechanisms to Clinical Management

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25605474

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Effects of levosimendan for low cardiac output syndrome in critically ill patients: systematic review with meta-analysis and trial sequential analysis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25605474

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00134-015-3659-7

1 reference

18 May 2018

1 reference

18 May 2018